PP_1170x120_10-25-21

Janssen Pharmaceutical Companies

Johnson & Johnson expands partnership with BARDA

Johnson & Johnson expands partnership with BARDA

NEW BRUNSWICK, N.J. — Johnson & Johnson announced Tuesday that its Janssen Pharmaceutical Companies will expand its existing partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health & Human Services, to seek treatment solutions for

Johnson & Johnson launches multi-pronged response to coronavirus

Johnson & Johnson launches multi-pronged response to coronavirus

NEW BRUNSWICK, N.J. — Johnson & Johnson announced that it is mobilizing resources at its Janssen Pharmaceutical Companies to launch a multi-pronged response to the novel coronavirus (also known as 2019-nCoV or Wuhan coronavirus) outbreak. As part of this work, the company has initiated efforts to develop a vaccine candidate against 2019-nCoV and broadly collaborate with others